查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1726303

全球類器官和球體市場：市場規模、佔有率、趨勢分析（按類型、應用、最終用途和地區）、細分市場預測（2025-2030 年）

Organoids And Spheroids Market Size, Share & Trends Analysis Report By Type, By Application (Developmental Biology, Personalized Medicine, Regenerative Medicine), By End Use, By Region And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

類器官和球體市場的成長和趨勢：

根據 Grand View Research, Inc. 的最新報告，全球類器官和球體市場規模預計到 2030 年將達到 62.7 億美元，2025 年至 2030 年的複合年成長率為 23.23%。

預計類器官培養在藥物研發中的應用日益增多以及全球整體對細胞治療和組織工程的需求不斷成長將推動市場的發展。

3D 球體被認為是組織工程和再生醫學研究的關鍵方面，因為它們可以用作生成複雜組織和器官的構建塊。此外，3D細胞培養可潛在地用作藥物篩檢和人類疾病分析的模型，預計在不久的將來為市場提供充足的成長機會。

採用類器官培養來評估人類特定疾病的機制的趨勢日益成長，預計市場將會成長。例如，人類類器官可用於分析多種組織，包括小腸、前列腺、大腦和肝臟。生成類似人體器官的 3D 細胞培養物為使用類器官作為細胞療法和作為整個器官移植的替代方案提供了巨大的潛力。

類器官和球體市場：概述

  • 按類型分類，類器官領域在 2024 年佔據市場最大收入佔有率，為 59.65%。類器官市場主要受藥物發現、疾病建模和個人化醫療對生理相關的 3D 細胞培養模型日益成長的需求所驅動。
  • 按應用分類，發育生物學領域在 2024 年佔據市場最大收益佔有率，為 30.17%。這是由於類器官和球體培養系統在發育生物學的應用越來越多。
  • 根據最終用途，生物技術和製藥業在 2024 年佔據市場最大收益佔有率，達到 46.32%。
  • 北美將主導類器官和球體市場，佔據 2024 年 34.72% 的最大收益佔有率。

目錄

第1章 分析方法與範圍

第2章執行摘要

3. 類器官和球體市場：促進因素、趨勢和範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 類器官和球體市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章 業務類型分析

  • 細分儀表板
  • 全球類器官和球體市場：按類型進行差異分析
  • 全球類器官和球體市場：市場規模和趨勢分析（按類型）（2018-2030 年）
  • 類器官
    • 類器官：市場評估與預測（2018-2030）
    • 類器官類型
    • 類器官（依技術分類）
    • 類器官來源
  • 球形體
    • 球體：市場估計與預測（2018-2030）
    • 球體：依類型
    • 球體：依方法
    • 球體：依原料

第5章 按最終用途分類的業務分析

  • 細分儀表板
  • 全球類器官和球體市場：依最終用途進行差異分析
  • 全球類器官和球體市場：按最終用途分類的市場規模和趨勢分析（2018-2030 年）
  • 生物技術和製藥
    • 生物技術和製藥：市場估計和預測（2018-2030）
  • 學術研究所
    • 學術研究機構：市場估計與預測（2018-2030）
  • 醫院和診斷中心
    • 醫院和診斷中心：市場估計和預測（2018-2030）

第6章 依應用程式進行的業務分析

  • 細分儀表板
  • 全球類器官和球體市場：按應用進行差異分析
  • 全球類器官和球體市場：按應用分類的市場規模和趨勢分析（2018-2030 年）
  • 發育生物學
    • 發育生物學：市場估計與預測（2018-2030）
  • 個人化醫療
    • 個人化醫療：市場評估與預測（2018-2030）
  • 再生醫學
    • 再生醫學：市場估計與預測（2018-2030）
  • 疾病病理學研究
    • 疾病病理學研究：市場估計與預測（2018-2030）
  • 藥物毒性和療效測試
    • 藥物毒性和療效測試：市場估計和預測（2018-2030）

第7章區域業務分析（按國家、類型、應用和最終用途）

  • 細分儀表板
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 北美：市場估計與預測（2018-2030年）
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲：市場估計與預測（2018-2030年）
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區：市場估計與預測（2018-2030 年）
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲：市場估計與預測（2018-2030年）
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 中東和非洲：市場估計與預測（2018-2030年）
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 公司分類
  • 戰略地圖
  • 公司地位分析（2024年）
  • 公司簡介/上市公司
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Lonza
    • 3D Biomatrix
    • 3D Biotek LLC
    • AMS Biotechnology（Europe）Limited
    • Cellesce Ltd
    • Corning Incorporated
    • Greiner Bio-One
    • Hubrecht Organoid Technology（HUB）
    • InSphero
    • Prellis Biologics
    • STEMCELL Technologies Inc.
Product Code: GVR-4-68038-843-5

Organoids And Spheroids Market Growth & Trends:

The global organoids and spheroids market size is expected to reach USD 6.27 billion by 2030, registering a CAGR of 23.23% from 2025 to 2030, according to a new report by Grand View Research, Inc., A rise in the adoption of organoid cultures in drug discovery, and rising demand for cell therapy and tissue engineering across the globe is expected to drive the market.

3D spheroids are considered as an important aspect of tissue engineering and regenerative medicine research as they can be used as building blocks for the generation of complex tissues and organs. In addition, the potential of 3D cell cultures to be used as models for drug screening and analysis of human disorders are expected to provide ample growth opportunities to the market in the near future.

A rise in the adoption of organoid cultures for the assessment of the mechanism of human-specific disorders is expected to enhance the market growth. For instance, human organoids have helped in the analysis of a wide range of tissues including the small intestine, prostate, brain, and liver. The promise of the generation of 3D cell cultures that resemble human organs has brought an enormous potential for the use of organoids as cell therapies, and as prospective substitutes for whole-organ transplantation.

Organoids And Spheroids Market Report Highlights:

  • Based on type, the organoids segment led the market with the largest revenue share of 59.65% in 2024. The organoid market is primarily driven by the increasing demand for physiologically relevant 3D cell culture models in drug discovery, disease modeling, and personalized medicine.
  • Based on application, the developmental biology segment led the market with the largest revenue share of 30.17% in 2024, owing to the rising usage of organoid and spheroid culture systems for developmental biology.
  • Based on end use, the biotechnology and pharmaceutical industries segment led the market with the largest revenue share of 46.32% in 2024.
  • North America dominated the organoids and spheroids market with the largest revenue share of 34.72% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Application
    • 1.1.3. End Use
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Organoids & Spheroids Market Variables and Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. High adoption of organoids & spheroids in drug discovery
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Rising demand for tissue engineering & organ transplantation
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Challenges associated with 3D cell culturing
      • 3.2.2.2. Ethical issues associated with organoid & spheroid cultures
  • 3.3. Organoids & Spheroids Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Organoids & Spheroids Market: Type Movement Analysis
  • 4.3. Global Organoids & Spheroids Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Organoids
    • 4.4.1. Organoids market estimates and forecast, 2018 - 2030
    • 4.4.2. Organoids by Type
      • 4.4.2.1. Neural Organoids
        • 4.4.2.1.1. Neural organoids market estimates and forecast, 2018 - 2030
      • 4.4.2.2. Hepatic Organoids
        • 4.4.2.2.1. Hepatic organoids market estimates and forecast, 2018 - 2030
      • 4.4.2.3. Intestinal organoids
        • 4.4.2.3.1. Intestinal organoids market estimates and forecast, 2018 - 2030
      • 4.4.2.4. Other organoids
        • 4.4.2.4.1. Other organoids market estimates and forecast, 2018 - 2030
    • 4.4.3. Organoids by Method
      • 4.4.3.1. General Submerged Method for Organoid Culture
        • 4.4.3.1.1. General Submerged Method for Organoid Culture market estimates and forecast, 2018 - 2030
      • 4.4.3.2. Crypt Organoid Culture Techniques
        • 4.4.3.2.1. Crypt Organoid Culture Techniques market estimates and forecast, 2018 - 2030
      • 4.4.3.3. Air Liquid Interface (ALI) Method for Organoid Culture
        • 4.4.3.3.1. ALI Method for Organoid Culture market estimates and forecast, 2018 - 2030
      • 4.4.3.4. Clonal Organoids from Lgr5+ Cells
        • 4.4.3.4.1. Clonal Organoids from Lgr5+ Cells market estimates and forecast, 2018 - 2030
      • 4.4.3.5. Brain and Retina Organoid Formation Protocol
        • 4.4.3.5.1. Brain and Retina Organoid Formation Protocol market estimates and forecast, 2018 - 2030
      • 4.4.3.6. Others
        • 4.4.3.6.1. Others market estimates and forecast, 2018 - 2030
    • 4.4.4. Organoids by Source
      • 4.4.4.1. Primary Tissues
        • 4.4.4.1.1. Primary tissues market estimates and forecast, 2018 - 2030
      • 4.4.4.2. Stem Cells
        • 4.4.4.2.1. Stem cells market estimates and forecast, 2018 - 2030
  • 4.5. Spheroids
    • 4.5.1. Spheroids market estimates and forecast, 2018 - 2030
    • 4.5.2. Spheroids by Type
      • 4.5.2.1. Multicellular tumor spheroids (MCTS)
        • 4.5.2.1.1. MCTS market estimates and forecast, 2018 - 2030
      • 4.5.2.2. Neurospheres
        • 4.5.2.2.1. Neurospheres market estimates and forecast, 2018 - 2030
      • 4.5.2.3. Mammospheres
        • 4.5.2.3.1. Mammospheres market estimates and forecast, 2018 - 2030
      • 4.5.2.4. Hepatospheres
        • 4.5.2.4.1. Hepatospheres market estimates and forecast, 2018 - 2030
      • 4.5.2.5. Embryoid bodies
        • 4.5.2.5.1. Embryoid bodies market estimates and forecast, 2018 - 2030
    • 4.5.3. Spheroids by Method
      • 4.5.3.1. Micropatterned Plates
        • 4.5.3.1.1. Micropatterned Plates market estimates and forecast, 2018 - 2030
      • 4.5.3.2. Low Cell Attachment Plates
        • 4.5.3.2.1. Low Cell Attachment Plates market estimates and forecast, 2018 - 2030
      • 4.5.3.3. Hanging Drop Method
        • 4.5.3.3.1. Hanging Drop Method for spheroid Culture market estimates and forecast, 2018 - 2030
      • 4.5.3.4. Others
        • 4.5.3.4.1. Other methods for spheroid culture market estimates and forecast, 2018 - 2030
    • 4.5.4. Spheroids by Source
      • 4.5.4.1. Cell Line
        • 4.5.4.1.1. Cell line market estimates and forecast, 2018 - 2030
      • 4.5.4.2. Primary Cell
        • 4.5.4.2.1. Primary cell market estimates and forecast, 2018 - 2030
      • 4.5.4.3. iPSCs Derived Cells
        • 4.5.4.3.1. iPSCs Derived Cells market estimates and forecast, 2018 - 2030

Chapter 5. End Use Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Organoids & Spheroids Market: End Use Movement Analysis
  • 5.3. Global Organoids & Spheroids Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Biotechnology and Pharmaceutical Industries
    • 5.4.1. Biotechnology and Pharmaceutical Industries market estimates and forecast 2018 to 2030 (USD million)
  • 5.5. Academic & Research Institutes
    • 5.5.1. Academic & Research Institutes market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Hospitals and Diagnostic Centers
    • 5.6.1. Hospitals and Diagnostic Centers market estimates and forecast 2018 to 2030 (USD million)

Chapter 6. Application Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Organoids & Spheroids Market: Application Movement Analysis
  • 6.3. Global Organoids & Spheroids Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Developmental Biology
    • 6.4.1. Developmental Biology market estimates and forecast 2018 to 2030 (USD million)
  • 6.5. Personalized Medicine
    • 6.5.1. Personalized Medicine market estimates and forecast 2018 to 2030 (USD Million)
  • 6.6. Regenerative Medicine
    • 6.6.1. Regenerative Medicine market estimates and forecast 2018 to 2030 (USD million)
  • 6.7. Disease Pathology Studies
    • 6.7.1. Disease Pathology Studies market estimates and forecast 2018 to 2030 (USD Million)
  • 6.8. Drug Toxicity & Efficacy Testing
    • 6.8.1. Drug Toxicity & Efficacy Testing market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Regional Business Analysis, By Country, Type, Application, & End Use

  • 7.1. Segment Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.4. Europe
    • 7.4.1. Europe Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. UK market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. France market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Denmark market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Sweden market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Target Disease Prevalence
      • 7.4.9.3. Competitive Scenario
      • 7.4.9.4. Norway market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.5.2. China
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. China market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.5.3. Japan
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Japan market estimates and forecast, 2018 - 2030 (Volume, Thousand)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. India market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Australia market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Target Disease Prevalence
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Target Disease Prevalence
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.6. Latin America
    • 7.6.1. Latin America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.7. MEA
    • 7.7.1. MEA Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Target Disease Prevalence
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.7.3. South Africa
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Target Disease Prevalence
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Target Disease Prevalence
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. UAE market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Target Disease Prevalence
      • 7.7.5.3. Competitive Scenario
      • 7.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Lonza
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. 3D Biomatrix
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. 3D Biotek LLC
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. AMS Biotechnology (Europe) Limited
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Cellesce Ltd
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Corning Incorporated
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Greiner Bio-One
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Hubrecht Organoid Technology (HUB)
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. InSphero
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Prellis Biologics
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. STEMCELL Technologies Inc.
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America organoids and spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 4 North America organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America organoids and spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 9 Canada organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 12 Mexico organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 13 Mexico organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Mexico organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 15 Europe organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 16 Europe organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Europe organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe organoids and spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 19 Germany organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 20 Germany organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 21 Germany organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 22 UK organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 23 UK organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 24 UK organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 25 France organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 26 France organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 27 France organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 28 Italy organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 29 Italy organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Italy organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 31 Spain organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 32 Spain organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Spain organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 34 Sweden organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 35 Sweden organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Sweden organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 37 Norway organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 38 Norway organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Norway organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 41 Denmark organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 42 Denmark organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 43 APAC organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 44 APAC organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 45 APAC organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 46 APAC organoids and spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 47 China organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 48 China organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 49 China organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 50 Japan organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 51 Japan organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Japan organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 53 India organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 54 India organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 55 India organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 56 Thailand organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 57 Thailand organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 58 Thailand organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 59 South Korea organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 60 South Korea organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 61 South Korea organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 62 Australia organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 63 Australia organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Australia organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 65 Latin America organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 66 Latin America organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 67 Latin America organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 68 Latin America organoids and spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 69 Brazil organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 70 Brazil organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Brazil organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 72 Argentina organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 74 Argentina organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa organoids and spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Africa organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 81 South Africa organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 85 UAE organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 87 UAE organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 88 Kuwait organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Kuwait organoids and spheroids market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Organoids and Spheroids: Market Outlook
  • Fig. 9 Organoids and Spheroids competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Organoids and Spheroids market driver impact
  • Fig. 13 Organoids and Spheroids market restraint impact
  • Fig. 14 Organoids and Spheroids market strategic initiatives analysis
  • Fig. 15 Organoids and Spheroids market: type movement analysis
  • Fig. 16 Organoids and Spheroids market: type outlook and key takeaways
  • Fig. 17 Neural organoids market estimates and forecast, 2018 - 2030
  • Fig. 18 Hepatic organoids market estimates and forecast, 2018 - 2030
  • Fig. 19 Intestinal organoids market estimates and forecast, 2018 - 2030
  • Fig. 20 Other organoids market estimates and forecast, 2018 - 2030
  • Fig. 21 General submerged method for organoid culture market estimates and forecast, 2018 - 2030
  • Fig. 22 Crypt organoid culture techniques market estimates and forecast, 2018 - 2030
  • Fig. 23 ALI method for organoid culture market estimates and forecast, 2018 - 2030
  • Fig. 24 Clonal Organoids from Lgr5+ Cells market estimates and forecast, 2018 - 2030
  • Fig. 25 Brain and Retina Organoid Formation Protocol market estimates and forecast, 2018 - 2030
  • Fig. 26 Others Organoid Formation Protocol market estimates and forecast, 2018 - 2030
  • Fig. 27 Primary tissues market estimates and forecast, 2018 - 2030
  • Fig. 28 Stem cells market estimates and forecast, 2018 - 2030
  • Fig. 29 Spheroids market estimates and forecast, 2018 - 2030
  • Fig. 30 MCTS market estimates and forecast, 2018 - 2030
  • Fig. 31 Neurospheres market estimates and forecast, 2018 - 2030
  • Fig. 32 Mammospheres market estimates and forecast, 2018 - 2030
  • Fig. 33 Hepatospheres market estimates and forecast, 2018 - 2030
  • Fig. 34 Embryoid bodies market estimates and forecast, 2018 - 2030
  • Fig. 35 Micropatterned plates market estimates and forecast, 2018 - 2030
  • Fig. 36 Low cell attachment plates market estimates and forecast, 2018 - 2030
  • Fig. 37 Hanging drop method for spheroid culture market estimates and forecast, 2018 - 2030
  • Fig. 38 Other methods for spheroid culture market estimates and forecast, 2018 - 2030
  • Fig. 39 Cell line market estimates and forecast, 2018 - 2030
  • Fig. 40 Primary cell market estimates and forecast, 2018 - 2030
  • Fig. 41 iPSCs derived cells market estimates and forecast, 2018 - 2030
  • Fig. 42 Organoids and spheroids market: End Use movement analysis
  • Fig. 43 Organoids and spheroids market: End Use outlook and key takeaways
  • Fig. 44 Biotechnology and pharmaceutical industries market estimates and forecast, 2018 - 2030
  • Fig. 45 Academic & research institutes market estimates and forecast, 2018 - 2030
  • Fig. 46 Hospitals and diagnostic centers market estimates and forecast, 2018 - 2030
  • Fig. 47 Organoids and spheroids market: application movement analysis
  • Fig. 48 Organoids and spheroids market: application outlook and key takeaways
  • Fig. 49 Developmental biology market estimates and forecast, 2018 - 2030
  • Fig. 50 Personalized medicine market estimates and forecast, 2018 - 2030
  • Fig. 51 Regenerative medicine market estimates and forecast, 2018 - 2030
  • Fig. 52 Disease pathology studies market estimates and forecast, 2018 - 2030
  • Fig. 53 Drug toxicity & efficacy testing market estimates and forecast, 2018 - 2030
  • Fig. 54 Global Organoids and spheroids market: regional movement analysis
  • Fig. 55 Global Organoids and spheroids market: regional outlook and key takeaways
  • Fig. 56 North America
  • Fig. 57 North America market estimates and forecast, 2018 - 2030
  • Fig. 58 US key country dynamics
  • Fig. 59 US market estimates and forecast, 2018 - 2030
  • Fig. 60 Canada key country dynamics
  • Fig. 61 Canada market estimates and forecast, 2018 - 2030
  • Fig. 62 Mexico key country dynamics
  • Fig. 63 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 64 Europe
  • Fig. 65 Europe market estimates and forecast, 2018 - 2030
  • Fig. 66 UK key country dynamics
  • Fig. 67 UK market estimates and forecast, 2018 - 2030
  • Fig. 68 Germany key country dynamics
  • Fig. 69 Germany market estimates and forecast, 2018 - 2030
  • Fig. 70 France key country dynamics
  • Fig. 71 France market estimates and forecast, 2018 - 2030
  • Fig. 72 Italy key country dynamics
  • Fig. 73 Italy market estimates and forecast, 2018 - 2030
  • Fig. 74 Spain key country dynamics
  • Fig. 75 Spain market estimates and forecast, 2018 - 2030
  • Fig. 76 Sweden key country dynamics
  • Fig. 77 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 78 Norway key country dynamics
  • Fig. 79 Norway market estimates and forecast, 2018 - 2030
  • Fig. 80 Denmark key country dynamics
  • Fig. 81 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 82 Asia Pacific
  • Fig. 83 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 84 China key country dynamics
  • Fig. 85 China market estimates and forecast, 2018 - 2030
  • Fig. 86 Japan key country dynamics
  • Fig. 87 Japan market estimates and forecast, 2018 - 2030
  • Fig. 88 India key country dynamics
  • Fig. 89 India market estimates and forecast, 2018 - 2030
  • Fig. 90 Australia key country dynamics
  • Fig. 91 Australia market estimates and forecast, 2018 - 2030
  • Fig. 92 Thailand key country dynamics
  • Fig. 93 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 94 South Korea key country dynamics
  • Fig. 95 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 96 Latin America
  • Fig. 97 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 98 Brazil key country dynamics
  • Fig. 99 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 100 Argentina key country dynamics
  • Fig. 101 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 102 Middle East and Africa
  • Fig. 103 Middle East and Africa market estimates and forecast, 2018 - 2030
  • Fig. 104 Saudi Arabia key country dynamics
  • Fig. 105 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 106 South Africa key country dynamics
  • Fig. 107 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 108 UAE key country dynamics
  • Fig. 109 UAE market estimates and forecast, 2018 - 2030
  • Fig. 110 Kuwait key country dynamics
  • Fig. 111 Kuwait market estimates and forecast, 2018 - 2030